Editorial
Published on 05 Oct 2023
Editorial: Manipulation of immune-vascular crosstalk in solid tumors
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1295953
- 519 views
Type at least 3 characters
5,345 articles
Articles
Original Research
Published on 05 Oct 2023
Intracellular Salmonella delivery of an exogenous immunization antigen refocuses CD8 T cells against cancer cells, eliminates pancreatic tumors and forms antitumor immunity
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1228532
- 3,676 views
Review
Published on 05 Oct 2023
Actin cytoskeleton remodeling at the cancer cell side of the immunological synapse: good, bad, or both?
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1276602
- 1,383 views
Mini Review
Published on 05 Oct 2023
Advances in the treatment of mycoses fungoides and Sézary syndrome: a narrative update in skin-directed therapies and immune-based treatments
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1284045
- 1,188 views
Original Research
Published on 05 Oct 2023
Combined signature of N7-methylguanosine regulators with their related genes and the tumor microenvironment: a prognostic and therapeutic biomarker for breast cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1260195
- 1,424 views
Original Research
Published on 05 Oct 2023
Construction of an m6A- and neutrophil extracellular traps-related lncRNA model to predict hepatocellular carcinoma prognosis and immune landscape
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1231543
- 1,038 views
Original Research
Published on 05 Oct 2023
Refined control of CRISPR-Cas9 gene editing in Clostridium sporogenes: the creation of recombinant strains for therapeutic applications
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1241632
- 1,839 views
Review
Published on 04 Oct 2023
Nivolumab adjuvant therapy for esophageal cancer: a review based on subgroup analysis of CheckMate 577 trial
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1264912
- 2,104 views
Original Research
Published on 04 Oct 2023
Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1212444
- 1,858 views
Mini Review
Published on 04 Oct 2023
Leveraging cryoablation and checkpoint inhibitors for high-risk triple negative breast cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1258873
- 1,379 views
Review
Published on 04 Oct 2023
Revolutionizing cancer treatment: nanotechnology-enabled photodynamic therapy and immunotherapy with advanced photosensitizers
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1219785
- 1,421 views
Review
Published on 03 Oct 2023
CD44v6, STn & O-GD2: promising tumor associated antigens paving the way for new targeted cancer therapies
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1272681
- 1,948 views
Systematic Review
Published on 03 Oct 2023
The entanglement of extracellular matrix molecules and immune checkpoint inhibitors in cancer: a systematic review of the literature
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1270981
- 1,552 views
Original Research
Published on 03 Oct 2023
Prediction of severe CRS and determination of biomarkers in B cell-acute lymphoblastic leukemia treated with CAR-T cells
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1273507
- 1,491 views
Original Research
Published on 02 Oct 2023
Tumor-infiltrating CCR2+ inflammatory monocytes counteract specific immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1267866
- 1,363 views
Case Report
Published on 02 Oct 2023
Case Report: Fatal cytomegalovirus pneumonia after CAR-T cell therapy in the long-term follow-up
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1226148
- 1,483 views
- 1 citation